Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5170 | 1593 | 39.6 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2307 | 4094 | HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PEGYLATION | Author keyword | 60 | 24% | 14% | 223 |
2 | MONOMETHOXYPOLYETHYLENE GLYCOL | Author keyword | 36 | 83% | 1% | 20 |
3 | BRANCHED PEG | Author keyword | 15 | 88% | 0% | 7 |
4 | PROTEIN PEGYLATION | Author keyword | 15 | 88% | 0% | 7 |
5 | SITE DIRECTED PEGYLATION | Author keyword | 9 | 83% | 0% | 5 |
6 | PROTEIN POLYMER CONJUGATE | Author keyword | 9 | 67% | 1% | 8 |
7 | GLYCOPEGYLATION | Author keyword | 6 | 80% | 0% | 4 |
8 | PROTEIN POLYMER CONJUGATES | Author keyword | 6 | 71% | 0% | 5 |
9 | PEG PROTEIN | Author keyword | 6 | 100% | 0% | 4 |
10 | PEG PROTEIN CONJUGATES | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PEGYLATION | 60 | 24% | 14% | 223 | Search PEGYLATION | Search PEGYLATION |
2 | MONOMETHOXYPOLYETHYLENE GLYCOL | 36 | 83% | 1% | 20 | Search MONOMETHOXYPOLYETHYLENE+GLYCOL | Search MONOMETHOXYPOLYETHYLENE+GLYCOL |
3 | BRANCHED PEG | 15 | 88% | 0% | 7 | Search BRANCHED+PEG | Search BRANCHED+PEG |
4 | PROTEIN PEGYLATION | 15 | 88% | 0% | 7 | Search PROTEIN+PEGYLATION | Search PROTEIN+PEGYLATION |
5 | SITE DIRECTED PEGYLATION | 9 | 83% | 0% | 5 | Search SITE+DIRECTED+PEGYLATION | Search SITE+DIRECTED+PEGYLATION |
6 | PROTEIN POLYMER CONJUGATE | 9 | 67% | 1% | 8 | Search PROTEIN+POLYMER+CONJUGATE | Search PROTEIN+POLYMER+CONJUGATE |
7 | GLYCOPEGYLATION | 6 | 80% | 0% | 4 | Search GLYCOPEGYLATION | Search GLYCOPEGYLATION |
8 | PROTEIN POLYMER CONJUGATES | 6 | 71% | 0% | 5 | Search PROTEIN+POLYMER+CONJUGATES | Search PROTEIN+POLYMER+CONJUGATES |
9 | PEG PROTEIN | 6 | 100% | 0% | 4 | Search PEG+PROTEIN | Search PEG+PROTEIN |
10 | PEG PROTEIN CONJUGATES | 6 | 100% | 0% | 4 | Search PEG+PROTEIN+CONJUGATES | Search PEG+PROTEIN+CONJUGATES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SITE SPECIFIC PEGYLATION | 93 | 63% | 6% | 93 |
2 | PEGYLATION | 47 | 25% | 10% | 160 |
3 | PROTEIN PEGYLATION | 38 | 42% | 4% | 70 |
4 | POLYETHYLENE GLYCOL INCREASES | 30 | 84% | 1% | 16 |
5 | LINEAR POLYETHYLENE GLYCOL | 24 | 91% | 1% | 10 |
6 | MODIFIED SUPEROXIDE DISMUTASE | 24 | 91% | 1% | 10 |
7 | HYBRID BLOCK COPOLYMERS | 22 | 38% | 3% | 46 |
8 | COVALENT ATTACHMENT | 22 | 17% | 7% | 118 |
9 | POLYETHYLENE GLYCOL MODIFIED PROTEINS | 19 | 63% | 1% | 19 |
10 | GIANT AMPHIPHILES | 17 | 50% | 2% | 25 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
PEGylation of therapeutic proteins | 2010 | 206 | 73 | 68% |
State of the art in PEGylation: The great versatility achieved after forty years of research | 2012 | 141 | 118 | 43% |
Chemistry for peptide and protein PEGylation | 2002 | 853 | 43 | 72% |
PEGylation, successful approach to drug delivery | 2005 | 809 | 37 | 51% |
PEG-modified biopharmaceuticals | 2009 | 145 | 65 | 72% |
Effect of pegylation on pharmaceuticals | 2003 | 1243 | 46 | 41% |
Process for protein PEGylation | 2014 | 15 | 117 | 65% |
FDA-approved poly(ethylene glycol)-protein conjugate drugs | 2011 | 119 | 66 | 36% |
Peptide and protein PEGylation: a review of problems and solutions | 2001 | 516 | 54 | 78% |
The impact of PEGylation on biological therapies | 2008 | 277 | 80 | 55% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BOLDERPATH INC | 5 | 60% | 0.4% | 6 |
2 | ENZYMOL PL | 3 | 100% | 0.2% | 3 |
3 | ORGAN SYNTH FUNCT SYST | 2 | 27% | 0.5% | 8 |
4 | DISRUPT HLTH TECHNOL | 2 | 67% | 0.1% | 2 |
5 | NORMAL BETHUNE MED | 2 | 43% | 0.2% | 3 |
6 | ORGAN CHEM MACROMOL CHEM 3 | 2 | 22% | 0.4% | 6 |
7 | BIOTECHNOL PHARMACEUT ENGN ZHEJIANG PRO | 1 | 31% | 0.3% | 4 |
8 | CHEM INVEST DRUGS | 1 | 25% | 0.2% | 3 |
9 | BIMOL MED | 1 | 50% | 0.1% | 1 |
10 | BIOASSAY DEV | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000132240 | ENZYME TECHNOL GRP//MODIFIED ENZYME//BIOTECHNOL STUDIES |
2 | 0.0000097825 | HPMA COPOLYMERS//HPMA COPOLYMER//POLYMER THER EUT |
3 | 0.0000075521 | POLYGLYCIDOL//HYBRID COPOLYMERIZATION//POLYME BATIMENT MXD |
4 | 0.0000075357 | RADIX OPHIOPOGONIS POLYSACCHARIDE//ENGN MODERN PREPARAT TECHNOL TCM//ENGN MODERN PREPARAT TECHNOL |
5 | 0.0000067759 | ACCELERATED BLOOD CLEARANCE ABC PHENOMENON//ANTI PEG IGM//ABC PHENOMENON |
6 | 0.0000066160 | ALLERGEN FRAGMENTS//AMPLIFICATION FREE//H2 GENOTYPE |
7 | 0.0000062534 | O PHTHALIC ANHYDRIDE//BULK COPOLYESTERIFICATION//POLYESTERIFICATION |
8 | 0.0000056913 | REVERSIBLE ADDITION FRAGMENTATION CHAIN TRANSFER RAFT//RAFT POLYMERIZATION//REVERSIBLE ADDITION FRAGMENTATION CHAIN TRANSFER |
9 | 0.0000055659 | CHAIN COPOLYMERIZATION//INHIBITORS OF AGGREGATION//INVIVO CULTURE |
10 | 0.0000053571 | L ASPARAGINASE//ASPARAGINASE//ERWINIA ASPARAGINASE |